| Interleukin‐17: a new paradigm in inflammation, autoimmunity, and therapy JM Kramer, SL Gaffen Journal of periodontology 78 (6), 1083-1093, 2007 | 246 | 2007 |
| The IL‐17 cytokine family SL Gaffen, JM Kramer, JY Jeffrey, F Shen Vitamins & hormones 74, 255-282, 2006 | 215 | 2006 |
| Cutting edge: evidence for ligand-independent multimerization of the IL-17 receptor JM Kramer, L Yi, F Shen, A Maitra, X Jiao, T Jin, SL Gaffen The Journal of Immunology 176 (2), 711-715, 2006 | 141 | 2006 |
| Cutting edge: evidence for ligand-independent multimerization of the IL-17 receptor JM Kramer, L Yi, F Shen, A Maitra, X Jiao, T Jin, SL Gaffen The Journal of Immunology 176 (2), 711-715, 2006 | 141 | 2006 |
| CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis JM Kramer, E Klimatcheva, TL Rothstein Journal of leukocyte biology 94 (5), 1079-1089, 2013 | 125 | 2013 |
| Innate immunity in Sjögren's syndrome J Kiripolsky, LG McCabe, JM Kramer Clinical immunology 182, 4-13, 2017 | 76 | 2017 |
| Recent advances in the etiology and treatment of burning mouth syndrome A Ritchie, JM Kramer Journal of Dental Research 97 (11), 1193-1199, 2018 | 71 | 2018 |
| Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor JM Kramer, W Hanel, F Shen, N Isik, JP Malone, A Maitra, W Sigurdson, ... The Journal of Immunology 179 (10), 6379-6383, 2007 | 70 | 2007 |
| Early events in Sjögren’s Syndrome pathogenesis: The importance of innate immunity in disease initiation JM Kramer Cytokine 67 (2), 92-101, 2014 | 64 | 2014 |
| Molecular concepts in the pathogenesis of ameloblastoma: implications for therapeutics T Jhamb, JM Kramer Experimental and molecular pathology 97 (3), 345-353, 2014 | 56 | 2014 |
| Current and emerging evidence for Toll-like receptor activation in Sjögren’s syndrome J Kiripolsky, JM Kramer Journal of immunology research 2018, 2018 | 53 | 2018 |
| Is it Sjögren's syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms H Aljanobi, A Sabharwal, B Krishnakumar, JM Kramer Oral surgery, oral medicine, oral pathology and oral radiology 123 (4), 482-495, 2017 | 47 | 2017 |
| Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction A Sharma, J Kiripolsky, E Klimatcheva, A Howell, F Fereidouni, ... Clinical immunology 164, 85-94, 2016 | 33 | 2016 |
| Transcriptomic and network analysis of minor salivary glands of patients with primary Sjögren’s syndrome A Oyelakin, E Horeth, EAC Song, S Min, M Che, B Marzullo, CJ Lessard, ... Frontiers in immunology 11, 606268, 2021 | 32 | 2021 |
| Myd88 is required for disease development in a primary Sjögren's syndrome mouse model J Kiripolsky, LG McCabe, DP Gaile, JM Kramer Journal of Leukocyte Biology 102 (6), 1411-1420, 2017 | 32 | 2017 |
| Activation of Myd88-dependent TLRs mediates local and systemic inflammation in a mouse model of primary Sjögren's syndrome J Kiripolsky, RA Romano, EM Kasperek, G Yu, JM Kramer Frontiers in immunology 10, 2963, 2020 | 31 | 2020 |
| Systemic manifestations of primary Sjögren's syndrome in the NOD. B10Sn-H2b/J mouse model J Kiripolsky, L Shen, Y Liang, A Li, L Suresh, Y Lian, QZ Li, DP Gaile, ... Clinical Immunology 183, 225-232, 2017 | 30 | 2017 |
| The osteopontin transgenic mouse is a new model for Sjögren's syndrome S Husain-Krautter, JM Kramer, W Li, B Guo, TL Rothstein Clinical Immunology 157 (1), 30-42, 2015 | 27 | 2015 |
| Transcriptomic and single-cell analysis of the murine parotid gland A Oyelakin, EAC Song, S Min, JE Bard, JV Kann, E Horeth, K Smalley, ... Journal of dental research 98 (13), 1539-1547, 2019 | 26 | 2019 |
| Fibromyxoma of the jaw: case report and review of the literature T Alhousami, A Sabharwal, S Gupta, A Aguirre, E Park, JM Kramer Head and Neck Pathology 12, 44-51, 2018 | 25 | 2018 |
